Skip to main content
Skip to content
Case File
d-25349House Oversight

Biopharmaceutical and Information Convergence Investment Performance Summary for New Leaf Funds

Other

The passage provides internal fund performance metrics without mentioning any individuals, government entities, or controversial transactions. It lacks actionable leads, novel allegations, or connecti New Leaf invested $945M in 64 biopharma deals with a 2.29x gross multiple. Information convergence sector saw $142M invested with a 2.62x gross multiple. Returns are presented gross of fees; net retu

Date
November 11, 2025
Source
House Oversight
Reference
House Oversight #024033
Pages
1
Persons
4
Integrity
No Hash Available
Loading document viewer...

Ask AI About This Document

0Share
PostReddit
Review This Document

Forum Discussions

This document was digitized, indexed, and cross-referenced with 1,500+ persons in the Epstein files. 100% free, ad-free, and independent.

Support This ProjectSupported by 1,550+ people worldwide
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.